Children's Research Institute Startup, Adipomics, Present Their Work at Congress During the First University Startups Demo Day
Children's National leadership and researchers meet with representatives from Washington, DC and MD
Washington, DC - Leadership and researchers from Children's National Health System spent the day on Capitol Hill meeting with representatives from the District of Columbia and Maryland and discussing the work conducted by the Children’s Research Institute (CRI). The focus was developing scientific research and transferring technologies from the lab bench to the marketplace. As part of the first University Startups Demo Day at Congress, organized by The National Council of Entrepreneurial Tech Transfer (NCET2), Children’s National showcased one of its medical technology startups, Adipomics.
Selected from a pool of 200 applicants as one of the “Best Startups in 2016,” Apidomics presented their work in improving diagnostics and treatment around childhood obesity. Greg Baker, PhD, Director, Innovation and Technology Commercialization, headed the team from CRI, accompanied by Evan Nadler, MD, Surgeon, and Co-Director, Children’s National Obesity Institute, and Robert Freishtat, MD, MPH, Emergency Medicine Specialist and President of Adipomics. The team spent the morning presenting the company to an audience of Global 1000 companies, angel investors, venture capitalists, and government attendees.
As part of the Demo Day events, the Adipomics team met with the offices of both Congresswoman Eleanor Holmes Norton (D-DC) and Congressman John Delaney (D-MD 6th District) and discussed the economic impact startup companies, spun out of Children’s National, could have on the greater Washington area’s economy. “We discussed our goals to translate our research efforts into pediatric products, commercialized by our startups, located in our area,” said Dr. Baker. “We presented to them how our researchers have successfully launched more than a dozen startup companies, which continues to further establish Children’s role as a leading innovation hub in the biomedical and bioengineering fields.”
Through its two research and academic arms, CRI and The Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National has successfully launched 15 startups over the past several years. Focused on innovation in pediatric surgery and on translational and clinical medical research, these startups range from robotics to pharmaceuticals and pain management to imaging and diagnostics. Adipomics was founded in 2015 with the goal of improving diagnostics and treatment around childhood obesity by developing an early detection method for diagnosing obesity. The diagnostic method can extract and fully assess adipocyte-derived exosomes from urine - allowing for a non-invasive early detection and longitudinal tracking tool for obesity-induced comorbid diseases.
About Children’s Research Institute
Research at Children’s National is conducted through Children’s Research Institute (CRI), the academic arm of Children’s National Health System. Children’s Research Institute research includes all translational, clinical, and community studies. Children’s Research Institute also oversees the educational activities and academic affairs of Children's National and the Department of Pediatrics at the George Washington University School of Medicine and Health Sciences.
Selected from a pool of 200 applicants as one of the “Best Startups in 2016,” Apidomics presented their work in improving diagnostics and treatment around childhood obesity. Greg Baker, PhD, Director, Innovation and Technology Commercialization, headed the team from CRI, accompanied by Evan Nadler, MD, Surgeon, and Co-Director, Children’s National Obesity Institute, and Robert Freishtat, MD, MPH, Emergency Medicine Specialist and President of Adipomics. The team spent the morning presenting the company to an audience of Global 1000 companies, angel investors, venture capitalists, and government attendees.
As part of the Demo Day events, the Adipomics team met with the offices of both Congresswoman Eleanor Holmes Norton (D-DC) and Congressman John Delaney (D-MD 6th District) and discussed the economic impact startup companies, spun out of Children’s National, could have on the greater Washington area’s economy. “We discussed our goals to translate our research efforts into pediatric products, commercialized by our startups, located in our area,” said Dr. Baker. “We presented to them how our researchers have successfully launched more than a dozen startup companies, which continues to further establish Children’s role as a leading innovation hub in the biomedical and bioengineering fields.”
Through its two research and academic arms, CRI and The Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National has successfully launched 15 startups over the past several years. Focused on innovation in pediatric surgery and on translational and clinical medical research, these startups range from robotics to pharmaceuticals and pain management to imaging and diagnostics. Adipomics was founded in 2015 with the goal of improving diagnostics and treatment around childhood obesity by developing an early detection method for diagnosing obesity. The diagnostic method can extract and fully assess adipocyte-derived exosomes from urine - allowing for a non-invasive early detection and longitudinal tracking tool for obesity-induced comorbid diseases.
Contact: Hani Ukayli at 202-476-4500
About Children’s Research Institute
Research at Children’s National is conducted through Children’s Research Institute (CRI), the academic arm of Children’s National Health System. Children’s Research Institute research includes all translational, clinical, and community studies. Children’s Research Institute also oversees the educational activities and academic affairs of Children's National and the Department of Pediatrics at the George Washington University School of Medicine and Health Sciences.